The wire › SEC Form 8-K
Calidi Biotherapeutics, Inc. CLDI
Filed with the SEC on Sep 25, 2026. Reported event date Sep 21, 2026.
- Business address
- San Diego, CA
- State
- California
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2836)
- SEC CIK
- 1855485
- Accession number
- 0001493152-26-044381
Items reported in this filing
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 8.01 Other Events
- Item 9.01 Financial Statements and Exhibits
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing